Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-22-023307
Filing Date
2022-09-30
Accepted
2022-09-30 16:18:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20220927_defa14a.htm DEFA14A 10776
2 card01.jpg GRAPHIC 157254
3 card02.jpg GRAPHIC 164841
  Complete submission text file 0001437749-22-023307.txt   455541
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 221284279
SIC: 2834 Pharmaceutical Preparations